21.05.2014 Views

Population PKPD Mode.. - Pharsight Corporation

Population PKPD Mode.. - Pharsight Corporation

Population PKPD Mode.. - Pharsight Corporation

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

What is RAS?<br />

<strong>Pharsight</strong> Reporting and Analysis Services (RAS) is a high quality resource for<br />

producing the clinical pharmacology study reports that are the basis of your<br />

regulatory submission document.<br />

Common Technical Document<br />

This is the RAS deliverable<br />

Module 5<br />

Clinical Study Reports<br />

RAS is a world class organization<br />

● Team experience on more than 400 client<br />

engagements<br />

● Experts with <strong>Pharsight</strong>'s leading PK/PD analysis<br />

and reporting software including WinNonlin®,<br />

WinNonlin AutoPilot, and other tools (e.g.,<br />

NONMEM)<br />

● Experienced in all major disease indications and<br />

development phases<br />

● Business representatives in the United States,<br />

Europe, and Japan to serve all major drug<br />

development geographies.<br />

Module 1<br />

Regional Info<br />

Module 4<br />

Non-clinical Study Reports<br />

Module 3<br />

Quality<br />

Module 2<br />

Common Technical Document Summaries<br />

Module 1<br />

Regional Info<br />

Module 1<br />

Regional Info<br />

slide 10<br />

© <strong>Pharsight</strong> <strong>Corporation</strong> All Rights Reserved

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!